CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
6.75
+0.05 (0.75%)
Aug 11, 2025, 12:52 PM - Market open
Paramount Global Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Paramount Global.
Price Target: $ (0.00%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Paramount Global is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2025 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $300 | Hold → Strong Buy | Upgrades | $300 | +4,344.44% | Sep 10, 2024 |
Brookline Capital | Brookline Capital | Strong Buy Initiates $9,000,000 | Strong Buy | Initiates | $9,000,000 | +133,333,233.33% | Feb 2, 2021 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $9,900,000 | Strong Buy | Initiates | $9,900,000 | +146,666,566.67% | Aug 24, 2020 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-23.02
from -466.45
EPS Next Year
-1.41
from -23.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | 38.8M |
Avg | n/a | n/a | 37.7M |
Low | n/a | n/a | 36.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -3.15 | -1.21 | -1.00 |
Avg | -23.02 | -1.41 | -1.41 |
Low | -41.29 | -1.58 | -1.78 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.